NCT05888987

Brief Summary

Microbial keratitis is a severe and often blindness-inducing pathology which represents today the first reason for long-term hospitalization (more than 5 days) in ophthalmology. Its diagnosis is clinical and leads to an immediate hospitalization in the presence of serious criteria (Mackie classification). The entire process of microbiological diagnosis requires several days before etiological confirmation and therefore delays the initiation of targeted therapy. Recently, new PCR systems allowing the detection of 18 to 27 pathogens in 75 minutes have been developed. Their use could thus be transposed to ophthalmology by adapting the microbiological diagnostic technique to samples currently taken by swabbing the cornea. The investigators will compare their diagnosis performance versus conventional methods on patients who suffered for a microbial keratitis with severity criteria.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
15mo left

Started Jul 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress69%
Jul 2023Aug 2027

First Submitted

Initial submission to the registry

May 25, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 5, 2023

Completed
1 month until next milestone

Study Start

First participant enrolled

July 7, 2023

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2027

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2027

Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

3.5 years

First QC Date

May 25, 2023

Last Update Submit

September 6, 2024

Conditions

Keywords

Severe infectious keratitisInfectious keratitisMicrobial keratitisCorneal infectionFilmArrayMultiplex PCR system

Outcome Measures

Primary Outcomes (1)

  • Time to modification of the first line antimicrobial treatment towards a treatment targeting the detected pathogen.

    At 2 weeks

Secondary Outcomes (5)

  • Duration of hospitalization

    At 1 month

  • Best corrected visual acuity

    At 12 months

  • Modification of the initial antimicrobial treatment after detection of the etiological agent

    At 1 month

  • Descriptive analysis of pathogens responsible for severe infectious keratitis in Champagne-Ardenne

    At 1 month

  • • Costs of diagnostic methods (conventional and FilmArray) and management (cost of the average length of stay in ophthalmology at the Reims University Hospital for severe infectious keratitis)

    At 1 month

Study Arms (2)

Before

After

Biological: PCR multiplex by FilmArray

Interventions

PCR multiplex by FilmArray system on corneal swabbing sample

After

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients treated for a severe corneal abscess according to the Mackie classification (requiring hospitalization) at the Reims University Hospital between 05/01/2022 and 04/30/2023 ("before" phase) and between 01/ 05/2023 and 04/30/2024 ("after" phase).

You may qualify if:

  • Over 18 years old
  • With social security affiliation
  • Willing to participate this study
  • Hospitalized in our department for severe infectious keratitis
  • Any prior (48 hours) or concomitant treatment with local or systemic antibiotherapy at time of corneal scrapping and swabbing
  • Patient not covered by the French Health Insurance
  • Unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Damien JOLLY

Reims, France

RECRUITING

Central Study Contacts

Alexandre DENOYER

CONTACT

Thomas Ferreira de Moura

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 25, 2023

First Posted

June 5, 2023

Study Start

July 7, 2023

Primary Completion (Estimated)

January 7, 2027

Study Completion (Estimated)

August 7, 2027

Last Updated

September 19, 2024

Record last verified: 2024-09

Locations